<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>86(4)</volume><submitter>Sia IG</submitter><pubmed_abstract>Tuberculosis (TB) poses a serious threat to public health throughout the world but disproportionately afflicts low-income nations. Persons in close contact with a patient with active pulmonary TB and those from endemic regions of the world are at highest risk of primary infection, whereas patients with compromised immune systems are at highest risk of reactivation of latent TB infection (LTBI). Tuberculosis can affect any organ system. Clinical manifestations vary accordingly but often include fever, night sweats, and weight loss. Positive results on either a tuberculin skin test or an interferon-γ release assay in the absence of active TB establish a diagnosis of LTBI. A combination of epidemiological, clinical, radiographic, microbiological, and histopathologic features is used to establ</pubmed_abstract><journal>Mayo Clinic proceedings</journal><pagination>348-61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3068897</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Current concepts in the management of tuberculosis.</pubmed_title><pmcid>PMC3068897</pmcid><pubmed_authors>Wieland ML</pubmed_authors><pubmed_authors>Sia IG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Current concepts in the management of tuberculosis.</name><description>Tuberculosis (TB) poses a serious threat to public health throughout the world but disproportionately afflicts low-income nations. Persons in close contact with a patient with active pulmonary TB and those from endemic regions of the world are at highest risk of primary infection, whereas patients with compromised immune systems are at highest risk of reactivation of latent TB infection (LTBI). Tuberculosis can affect any organ system. Clinical manifestations vary accordingly but often include fever, night sweats, and weight loss. Positive results on either a tuberculin skin test or an interferon-γ release assay in the absence of active TB establish a diagnosis of LTBI. A combination of epidemiological, clinical, radiographic, microbiological, and histopathologic features is used to establ</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Apr</publication><modification>2025-04-21T21:13:01.963Z</modification><creation>2019-03-27T00:40:16Z</creation></dates><accession>S-EPMC3068897</accession><cross_references><pubmed>21454737</pubmed><doi>10.4065/mcp.2010.0820</doi></cross_references></HashMap>